Navigation Links
Merz Pharmaceuticals Announce Three Studies of NT-201 - (Botulinum neurotoxin type A Free From Complexing Proteins)
Date:6/9/2009

on the DAS (therapeutic domains of hygiene, dressing, limb position, and pain). Efficacy was assessed as very good or good by the majority of investigators, patients and caregivers (range from 56.3% to 85.3%). During the 1-year trial period, adverse events were observed in 56.6% of patients. None of the patients had positive antibody titer tested in the mouse diaphragm assay.

About Merz

Merz (KGAa) is known worldwide for its development of original compounds and formulations for medical professionals and consumers in 90 countries. Globally, Merz is a leader in research and development of pharmaceuticals for the treatment of neurological and psychological disorders as well as for aesthetic dermatology, including products for the treatment of wrinkles and aging skin, hair loss and acne. Research is concentrated in fields that have a strong need for therapeutic innovation such as Alzheimer's disease, Parkinson's disease, tinnitus, chronic pain conditions, addictions, and neuromuscular disturbances.

Merz Pharmaceuticals, LLC is the wholly owned, US subsidiary of the Merz Group of Companies. A specialty pharmaceutical company, Merz Pharmaceuticals, LLC was established in 1995 and is responsible for the commercialization of Merz (KGAa) products in the US.


'/>"/>
SOURCE Merz Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. ISTA Pharmaceuticals Announces Positive Results for Phase 2 Study of Low-Dose Bromfenac in Dry Eye Disease
2. Merz Pharmaceuticals Announces Results of Clinical Trials with NT-201(Botulinum neurotoxin type A free from complexing proteins) at Annual Movement Disorders Society Meeting
3. Arena Pharmaceuticals Announces Lorcaserin Data Demonstrating Highly Significant Categorical and Absolute Weight Loss and Improvements in Secondary Endpoints Associated with Cardiovascular Risk
4. Access Pharmaceuticals Announces Publication of Thiarabine Combination Data
5. Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials
6. Arena Pharmaceuticals Announces the Presentation of Lorcaserin Phase 3 BLOOM Data at the American Diabetes Associations 69th Scientific Sessions
7. Keryx Biopharmaceuticals Announces Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer
8. Keryx Biopharmaceuticals Reports Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer
9. Keryx Biopharmaceuticals Reports Single Agent Phase 2 Data of KRX-0401 (Perifosine) Further Demonstrating KRX-0401s Activity in the Treatment of Advanced Metastatic Renal Cell Cancer
10. Poniard Pharmaceuticals Announces Progression-Free Survival Data From Phase 2 Clinical Trial of Picoplatin in Metastatic Colorectal Cancer
11. Kinex Pharmaceuticals To Present at ASCO 2009 Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... Denmark and ATLANTA , August ... the US Food and Drug Administration (FDA) cleared the MagVita ... in adult patients who have failed to receive satisfactory improvement ... a non-invasive technique for stimulating neural tissue in the part ... Disorder. The procedure has been proven safe and effective and ...
(Date:8/28/2015)... y LONDRES, 28 de agosto de ... PHIA) anunció hoy su participación en el  Congreso ... sus soluciones cardiológicas más recientes y novedosas, entre ... que conectan a las personas y la tecnología ... ayudar a diagnosticar, guiar los tratamientos y permitir ...
(Date:8/27/2015)... FRANKLIN, Mass. , Aug. 27, 2015 /PRNewswire/ ... in the KSSTA Knee Journal, compared the Arthrosurface ... "inlay" Arthroplasty design, versus an "onlay" design implant ... showed similar improvements in function and pain scores, ... showed progression of osteoarthritis (OA). However, 53% of ...
Breaking Medicine Technology:Therapy System for Treating Major Depressive Disorder Receives FDA Clearance 2Therapy System for Treating Major Depressive Disorder Receives FDA Clearance 3Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 2Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 3Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 4Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 5Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 2Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 3
... Osteotech, Inc. (Nasdaq: OSTE ), a leader in ... announced it is highlighting three procedure-specific MagniFuse(TM) bone grafting products ... Society (NASS) 2009 Annual Meeting, taking place November 10th through ... been used in 40 spinal surgeries in the ...
... Inc. (Nasdaq: VVUS ) today announced that Timothy Morris, chief ... Lazard Capital Markets 6th Annual Healthcare Conference. , The VIVUS presentation ... on Wednesday, November 18, 2009 at 1:45 p.m. ET. A ... at http://ir.vivus.com . , About VIVUS ...
Cached Medicine Technology:Osteotech Highlights Three Procedure-Specific MagniFuse(TM) Bone Grafting Products at the NASS 2009 Annual Meeting 2Osteotech Highlights Three Procedure-Specific MagniFuse(TM) Bone Grafting Products at the NASS 2009 Annual Meeting 3Osteotech Highlights Three Procedure-Specific MagniFuse(TM) Bone Grafting Products at the NASS 2009 Annual Meeting 4Osteotech Highlights Three Procedure-Specific MagniFuse(TM) Bone Grafting Products at the NASS 2009 Annual Meeting 5VIVUS to Present at Lazard Capital Markets Healthcare Conference 2
(Date:8/31/2015)... ... 2015 , ... healthbeautydistributors.com has been in business since 2005 ... doctor note service to be made available to all patients and family members ... excuse, much less than the average daily pay of workers. , Interested ...
(Date:8/30/2015)... ... August 30, 2015 , ... ProTrailer Party is a new and ... contains 30 styled and detailed presets, allowing FCPX users to immerse the audience ... titles will help film makers save time while adding professional titles to every project. ...
(Date:8/30/2015)... ... August 31, 2015 , ... Negotiating an FDA Import Hold Crisis:, Strategies for ... EDT, http://www.fdanews.com/importholdcrisis , US authorities are holding imports more than ever before, ... , With alerts on an uptick and a new final rule, having a top-notch ...
(Date:8/30/2015)... IL (PRWEB) , ... August 30, 2015 , ... ... is pleased to announce that Partner Daniel M. Kotin was recently elected ... this exclusive organization constitutes the highest degree of peer recognition and outstanding professionalism. ...
(Date:8/30/2015)... ... August 30, 2015 , ... ... the company as the new Global Communications Director for InHealth Media. Mr. ... having spent the last 16 years doing on-air television, producing shows, on air-radio ...
Breaking Medicine News(10 mins):Health News:FCPX Effects Developer Releases ProTrailer Party for Final Cut Pro X 2Health News:FDAnews Announces — Negotiating an FDA Import Hold Crisis: Strategies for Challenging FDA Findings Webinar, Sept. 22, 2015 2Health News:FDAnews Announces — Negotiating an FDA Import Hold Crisis: Strategies for Challenging FDA Findings Webinar, Sept. 22, 2015 3Health News:Chicago Personal Injury Lawyer Daniel M. Kotin Elected to the American Board of Trial Advocates 2Health News:Chicago Personal Injury Lawyer Daniel M. Kotin Elected to the American Board of Trial Advocates 3Health News:InHealth Media Appoints New Global Communications Director 2
... , , LOS ANGELES, Sept. 1 ... Congress, the largest medical tourism congress in the world, announces ... 26-28th 2009 in Los Angeles, California. http://www.medicaltourismcongress.com ... private one-on-one networking sessions will be arranged through special networking ...
... , , , ... the U.S. compression therapy market is necessitating the introduction of ... the concept of evidence-based medicine to educate physicians and encourage ... has spurred the demand for early diagnosis and preventive approaches. ...
... Barcelona, Spain, 1 September: An increasing number of heart ... devices, i.e. cardiac resynchronization therapy (CRT). Recently completed ... provide evidence of a growing number of CRT patients, ... cardiac devices and the simultaneous need for increased efficiency ...
... LOS ANGELES, Sept. 1 FertilityTies, a social network ... well as features that appeal to those struggling with infertility ... FertilityTies is a comprehensive online community affiliated with ... faced with infertility or trying to conceive. www.FertilityTies.com ...
... NATICK, Mass. and BARCELONA, Sept. 1 ... announced long-term data from the Prevention of Sudden Cardiac ... that implantable cardioverter defibrillators (ICDs) were associated with a ... implanted in patients following myocardial infarction (heart attack). ...
... ALISO VIEJO, Calif., Sept. 1 Clarient, Inc. (Nasdaq: ... pathologists, oncologists and the pharmaceutical industry, today announced that it is ... New York City. , , The ... Annual Healthcare Conference at 2:50 pm EDT on Wednesday, September 9. ...
Cached Medicine News:Health News:World's Largest Medical Tourism and Global Healthcare Conference, October 26-28th, Announces Record Attendance, Distinguished Speakers and Sponsors 2Health News:U.S. Compression Therapy Market to Reach $1.16 Billion in 2015, Finds Frost & Sullivan 2Health News:U.S. Compression Therapy Market to Reach $1.16 Billion in 2015, Finds Frost & Sullivan 3Health News:U.S. Compression Therapy Market to Reach $1.16 Billion in 2015, Finds Frost & Sullivan 4Health News:FertilityTies, Social Network for the Fertility-Focused Unveils New Site Design, Unique Features to Help Patients Find Fertility Doctors & More 2Health News:PreSCD II Registry Shows ICDs Lead to 44 Percent Reduction in Mortality for Heart Attack Survivors 2Health News:PreSCD II Registry Shows ICDs Lead to 44 Percent Reduction in Mortality for Heart Attack Survivors 3Health News:Clarient to Present at Upcoming Investment Conferences in New York City 2
... Designed with patient need and ... Orthotic Appliance) family of products effectively ... indications. The Chairback frame attachment provides ... orthosis (LSO) provides superior support for ...
Effectively stabilize and relax your back with the LumboTrain back support....
... to superior immobilization and cervical spine care, one ... already know that the most important function of ... But what you may not know is that ... provides superior immobilization over the leading one-piece rigid ...
Distinct male and female designs for proper anatomical fit. Hip and pelvic components sized independently. Rigid posterior tongue minimizes pelvic rotation. Available in black or white plastic. Aggre...
Medicine Products: